Key Findings
The Japan Alzheimer’s disease therapeutics and diagnostics market is estimated to record a CAGR of 5.83% during the forecast period, 2021-2026. The increasing R&D activities are augmenting the market growth in Japan. 2020 is the base year for the study.

Market Insights
The R&D activities, with regard to Alzheimer’s detection, are on the rise in Japan. Also, the total understanding of the disease pathology has increased in the past few years. Academia has been producing quality R&D despite the lack of industry-funded R&D activities, which is set to result in commercially marketed products in the coming years. Moreover, at present, there are 15 active clinical trials under development for Alzheimer’s disease. The country is also set to witness an increase in its geriatric population. A robust healthcare program is in place for addressing the rising demand for the surging geriatric population affected with dementia. Further, with effective public policies and dedicated academic research in terms of introducing new interventions for Alzheimer’s, the market is predicted to fare well in Japan.

Competitive Insights
Some of the esteemed players in the market include, Novartis AG, Lupin Limited, Sun Pharmaceuticals Industries Ltd, Baxter International Inc, Eisai Co Ltd, GE Healthcare, Eli Lilly & Company, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments